← Back to Search

Behavioral Intervention

Augmented Care at Worksite for Prediabetes

N/A
Waitlist Available
Led By Carla Miller, Ph.D.
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-months and 18-months
Awards & highlights

Study Summary

This trial will test if adding extra support to a diabetes prevention program will help employees with prediabetes who haven't had success with the standard program.

Eligible Conditions
  • Prediabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-months and 18-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12-months and 18-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent Weight Change
Secondary outcome measures
Fasting Glucose

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group Lifestyle Balance Plus (GLB+)Experimental Treatment1 Intervention
Augmented lifestyle intervention for early slow responders
Group II: Group Lifestyle Balance (GLB)Active Control1 Intervention
Standard lifestyle intervention to promote weight loss
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Lifestyle Balance Plus (GLB+)
2018
N/A
~210

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
827 Previous Clinical Trials
502,543 Total Patients Enrolled
Carla Miller, Ph.D.Principal Investigator - The Ohio State University (during study implementation)
Ohio State University

Media Library

Group Lifestyle Balance Plus (GLB+) (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03382873 — N/A
Prediabetes Research Study Groups: Group Lifestyle Balance (GLB), Group Lifestyle Balance Plus (GLB+)
Prediabetes Clinical Trial 2023: Group Lifestyle Balance Plus (GLB+) Highlights & Side Effects. Trial Name: NCT03382873 — N/A
Group Lifestyle Balance Plus (GLB+) (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03382873 — N/A
Prediabetes Patient Testimony for trial: Trial Name: NCT03382873 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the recruitment rate of this clinical trial?

"Affirmative. Clinicaltrials.gov records show that this experiment is presently recruiting, having been posted on February 8th 2018 and most recently updated on the 23rd of Feb 2021. It requires 236 volunteers from a single site to be recruited."

Answered by AI

Are there any openings in the program that would allow participants to join?

"Indeed, clinicaltrials.gov confirms that this medical trial is in the recruitment phase. This study was initially uploaded on February 8th of 2018 and underwent its most recent update on February 23rd 2021."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
What site did they apply to?
The Ohio State University
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1

Why did patients apply to this trial?

I'd like to learn more about diabetes and how to manage it.
PatientReceived no prior treatments
Recent research and studies
~29 spots leftby Apr 2025